Atlas Trials

Surgical Window of Opportunity Study of Orally Administered BAY 2402234 in Recurrent Glioma

Clinical trial NCT05061251 · WITHDRAWN

Trial details

NCT number
NCT05061251
Sponsor
University of Texas Southwestern Medical Center
Status
WITHDRAWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
GliomaIDH Mutation
Start date
2021-12-01
Primary completion
2022-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.